The vote was 50-46. Six Republicans voted for Dr. Califf, and five Democrats voted against.
TheTimesstated that Democrats are concerned about Dr. Califf’s stance on opioids: In 2016 and 2017, under Dr. Califf’s leadership, FDA approved five new opioids, in spite of the fact that the opioid epidemic had already killed thousands. On the Republican side, anti-abortion advocates are upset that during Dr. Califf’s prior tenure, FDA eased access to medication abortion pills.
UPDATE:The Council for Responsible Nutrition (CRN) has issued a press release applauding the nomination. Steve Mister, CRN President and CEO, stated the following:
“Congratulations to Dr. Califf on his confirmation as FDA Commissioner. CRN supports his confirmation, and we look forward to working with Dr. Califf and other FDA leaders to keep strengthening the dietary supplement and functional food industry and protecting consumers’ ability to access safe and beneficial products. We’ll do this together by ensuring products continue to meet all regulatory requirements.
“Dr. Califf’s confirmation comes at a pivotal time for this industry," Mister continued. "Consumers are more proactive than ever about their health—four out of five Americans use a dietary supplement, according to CRN’s latest consumer survey. This industry needs a robust and responsive FDA that enforces the law, addresses safety concerns, and provides incentives for continued innovation and high-quality manufacturing. As Dr. Califf begins planning his agenda, we urge him to prioritize the following action items:
- Increase funding to the Office of Dietary Supplement Programs (ODSP) at FDA, recognizing this Office must keep pace with the rapidly growing industry it oversees
- Work with Congress to enact legislation to establish mandatory product listing for supplements
- Establish a legal pathway to market for hemp-derived cannabidiol (CBD) as a dietary supplement
- Issue final guidance on the labeling of probiotics
- Issue final guidance for new dietary ingredients, along with an official list of pre-DSHEA dietary ingredients that are “grandfathered” under the 1994 law
- Protect consumers and strengthen incentives for innovation with more proactive enforcement of the existing law for dietary supplements
UPDATE:The Natural Products Association has released a statement congratulating Dr. Califf. “This agency has been on the front lines of the pandemic for over two years, and we salute them for their extraordinary work during this time," said Daniel Fabricant, Ph.D., President and CEO of NPA. "Nonetheless, there are still glaring deficiencies in establishing a reasonable regulatory approach for certain products like CBD and NAC that need to be addressed immediately. We look forward to working with Dr. Califf and the agency in a productive fashion to ensure consumers continue to enjoy safe and accessible natural products. Americans are turning more and more to natural products to prevent illness and support their immune systems, and we want to work together to ensure that this healthy trend continues."
UPDATE:The American Herbal Products Association (AHPA) looks forward to working with Dr. Califf, according to a statement from AHPA President Michael McGuffin, who said:
This story is breaking. Check back for updates.
Related: Industry Associations React to FDA Commissioner Nomination FDA Commissioner Nominated; CRN Notes Top 6 Priorities